Cells have developed a surprising transportation system for their endosomes

NewsGuard 100/100 Score

Cells have developed a surprising transportation system for their endosomes, according to research published today in Physical Review Letters, "Dynamics and Spatial Organization of Endosomes in Mammalian Cells."

By marking endosomes with fluorescent tags and watching them move in live cells, Samir Mitragotri, a University of California, Santa Barbara (UCSB) professor of chemical engineering, and graduate students Chinmay Pangarkar and Anh Tuan Dinh learned that the endosomes travel to the cell's nucleus using back-and-forth symmetrical movement, rather than taking a more direct route. This forward and reverse motion leads to even distribution of the endosomes on microtubules.

An aster-like layout of the microtubules helps the endosomes accumulate at the nucleus. The researchers think this non-direct approach to the nucleus has evolved to allow hundreds of endosomes to bring nutrients and molecular information to the cell's center for processing. Even if the cell moves or if there's increased traffic flow, there's never a traffic jam on the microtubules.

While it has long been known that endosomes travel in a bidirectional way, it has not previously been established that the transport system is symmetrical. The authors believe that because a number of neurological, muscular and cardiac diseases stem from the malfunctioning of one or more proteins that regulate the transport properties of endosomes or lysosomes, it may be possible to perform in silico and/or laboratory experiments to better understand the relationship between transport properties and pathology.

The delivery of many therapeutic agents, especially DNA and siRNA is dependent on endocytic transport. Understnading how endosome distribution evolves is central to such therapeutic approaches.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First-of-its-kind AI tool predicts patient response to cancer drugs at single-cell resolution